Fluorescence In Situ Hybridization Imaging Systems Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Published Date : May 2021 | No. of Pages : 250 Pages | Category : Healthcare

The global Fluorescence In Situ Hybridization Imaging Systems market size was valued at US$ 804.5 Million in 2020 and is anticipated to grow at a CAGR of 8.1 % during forecast period 2021 to 2030.

Growth Factors

The growing prevalence of target diseases leads to clinical urgency for the adoption of rapid diagnostic alternatives such as Fluorescence In Situ Hybridization (FISH) imaging systems, which is anticipated to fuel demand in the coming years. In addition, rising awareness about the associated benefits of this system, such as rapid analysis, enhanced visualization, high precision of results, and a wide range of application, is also among the major factors responsible for increased adoption.

The market is also predominantly driven by technologically advanced products in the field of in-vitro diagnostics. For instance, the advent of 3D FISH technology is one of the major advancements responsible for increased demand for FISH imaging systems. It facilitates three-dimensional visualization and analysis of target cells, thereby improving the potential for positive research outcomes. Positive research outcomes, reduced procedural time, ease of usage, and greater probe labeling efficiency are some of the benefits associated with the use of FISH imaging, and this is also expected to boost demand.

Moreover, a combination of FISH imaging equipment with other advanced technologies, such as high-throughput automated imaging systems & software, which yields faster, more efficient, and clear results, is expected to accelerate growth over the coming years. This is also anticipated to create new avenues for research applications.

Report Highlights

instruments held the dominant share because of greater adoption owing to benefits offered by imaging systems such as microscopes, spectrophotometers, and others. In addition, services are expected to grow exponentially during the forecast period owing to their increased adoption due to higher cost-efficiency.

The services segment is anticipated to witness lucrative CAGR during the forecast period owing to the need for a more complex and multilayered drug development system. FISH imaging services are likely to be essential in this system due to the formulation of new combinations and therapies that require higher precision.

Industry players are developing a range of services to simplify the overall process. These services are expected to result in a reduction of overall expenditure due to which they are likely to be preferred by researchers and scientists. The lucrative growth of this segment can also be attributed to increasing outsourcing to improve operations and ensure high adherence to quality standards.

Other benefits include cost advantages, increased efficiency of services, enhanced productivity, and a higher focus on core areas of development, which are critical to a company's growth. According to an NCBI survey, outsourcing results in cost savings of up to 60% and ensures better quality. In addition, contract services eliminate the need for infrastructure, which leads to significant cost reduction.

Cancer diagnostics accounted for a substantial share in the application segment. This can be attributed to the growing prevalence of diseases, such as cancer and genetic abnormalities. In addition, the high demand for accurate, sensitive, and rapid diagnosis of cancer is expected to lead to the growth of this segment.

Moreover, a growing number of research initiatives by major players for the development of advanced systems is expected to increase the scope for growth. This is anticipated to further boost the adoption of cancer diagnostics during the forecast period.

On the other hand, genetic diseases are expected to witness growth at a lucrative CAGR during the forecast period. Technological advancements are expected to lead to the exponential growth of this segment over the coming years.

An increase in the incidence of rare diseases caused by genetic aberrations is a high impact rendering driver for genetic disease testing. According to data published in NCBI, 80% of rare diseases are caused by genetic abnormalities.

In 2016, diagnostic laboratories accounted for the largest share in the end-use segment, as this technique is used for the detection of leukemia, myelodysplastic syndrome, multiple myeloma, and chromosomal abnormalities. On the other hand, an increasing number of research initiatives for cell research is expected to fuel growth.

The clinical diagnostics segment held a dominant share, and this can be attributed to the adoption of this technique in a wide range of applications, such as diagnosis of cancer, infectious diseases, genetic disorders, and others. The major benefits of these systems, including high speed for conducting assays, have made them one of the key cytogenetic diagnostic procedures.

The high prevalence of breast cancer is one of the major factors responsible for fueling the adoption of this technique for clinical purposes. It is the second-largest cause of cancer-related deaths and a major contributor to world mortality rates. According to the American Cancer Society, in 2017, around 252,710 new cases of breast cancer are expected to be diagnosed globally and this number is anticipated to grow over the coming years.

These systems possess the ability to automatically quantify various parameters, such as the stage of the disease and cell viability, as compared to conventional cytogenetics. These benefits are expected to drive the fluorescence in situ hybridization imaging systems market over the forecast period. In addition, technological advancements such as integration with a lab-on-a-chip microfluidic device are anticipated to propel the growth.

In 2016, North America held a dominant share of the industry. Key players are entering into collaborations to expand their product portfolios and improve their revenue share, which is a major factor contributing to growth across this region. The major share held by this region can also be attributed to extensive research & new product developments by major players.

The Asia Pacific region is expected to exhibit exponential growth during the forecast period. This can be attributed to growing healthcare spending and awareness among researchers and pathologists about the benefits of this technique in diagnostics. In addition, some of the prominent market players are consistently promoting the adoption of these systems through various initiatives, and this is also expected to propel demand in the region.

Growing awareness in emerging economies, such as India and China, coupled with extensive economic development in these countries is also anticipated to create significant growth opportunities in this market.

Key Players

Leica BiosystemsNussloch GmbH; Thermo Fisher Scientific, Inc.; and PerkinElmer, Inc.

Market Segmentation

  • Product Outlook

    • Instruments

      • Microscopes

      • Automated cell analyzers

      • Others

    • Consumables & Accessories

    • Services

    • Software

  • Application Outlook 

    • Cancer Diagnosis

      • Lung cancer

      • Breast cancer

      • Others

    • Genetic Disease Diagnosis

    • Others

  • End-use Outlook

    • Diagnostic Laboratories

    • Research & Academic Institutes

    • Others

  • Regional Outlook

    • North America

      • The U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • The Middle East & Africa

      • South Africa

      • Saudi Arabia

The Fluorescence In Situ Hybridization Imaging Systems market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Fluorescence In Situ Hybridization Imaging Systems market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Fluorescence In Situ Hybridization Imaging Systems market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fluorescence In Situ Hybridization Imaging Systems market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Fluorescence In Situ Hybridization Imaging Systems market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Fluorescence In Situ Hybridization Imaging Systems capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Fluorescence In Situ Hybridization Imaging Systems by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Fluorescence In Situ Hybridization Imaging Systems market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Fluorescence In Situ Hybridization Imaging Systems market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Fluorescence In Situ Hybridization Imaging Systems market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Fluorescence In Situ Hybridization Imaging Systems industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Fluorescence In Situ Hybridization Imaging Systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Fluorescence In Situ Hybridization Imaging Systems market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Fluorescence In Situ Hybridization Imaging Systems market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Fluorescence In Situ Hybridization Imaging Systems market. These factors have benefited the growth of the global market for Fluorescence In Situ Hybridization Imaging Systems. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Fluorescence In Situ Hybridization Imaging Systems. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Fluorescence In Situ Hybridization Imaging Systems are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

Featured Research Reports

  • Featured Research Reports

    Healthcare Testing, Inspection, And Certification Outsourcing Market (By Services: Testing, Inspection, Certification; By Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Pupillometer Market (By Mobility: Table-top, Hand-held; By Type: Video, Digital; By End-use: Hospitals, Eye Clinics; By Application: Ophthalmology, Oncology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    North America And Europe Preclinical Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Cell Banking Outsourcing Market (By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking; By Cell Type; By Phase) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Biologics Contract Development Market (By Source: Mammalian, Microbial; By Product Service Type; By Indication: Oncology, Immunological Disorders) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030